Senior insider sale
President and CEO at VERA THERAPEUTICS, INC. — senior position signals high conviction
$4.87M
129.50K shares
What this filing means
FORDYCE MARSHALL plans to sell 129.50K shares of VERA THERAPEUTICS, INC. valued at approximately $4.87M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001950047-26-009028
DirectorOfficer· President and CEO
Since May 2021
129.50K
Shares to sell
$4.87M
Approx. market value
64.75K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/2/2026
64.75KTotal acquired64.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/2/2026 | Exercise of Stock Options Cash | 64.75K | — |
| Total | 64.75K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
46.25K
Market value
$1.96M
7/7/2026
—Completed
Units to sell
18.50K
Market value
$701.8K
6/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
64.75K
Market value
$2.22M
9/2/2026
Total
Units
129.50K
Value
$4.87M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/7/2026 | 46.25K | $1.96M | — | Completed |
6/23/2026 | 18.50K | $701.8K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 64.75K | $2.22M | NASDAQ | Planned |
| Total | 129.50K | $4.87M | ||